RB Davis

1.4k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

RB Davis is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, RB Davis has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in RB Davis's work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Neutropenia and Cancer Infections (4 papers). RB Davis is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Neutropenia and Cancer Infections (4 papers). RB Davis collaborates with scholars based in United States and Israel. RB Davis's co-authors include Jay S. Loeffler, Thomas M. Moriarty, Howard A. Fine, E Alexander, Peter McL. Black, Hanne M. Kooy, Patrick Y. Wen, Samuel Kopel, Philip Schulman and Robert W. Carey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

RB Davis

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases

1995 447 citations E Alexander, Thomas M. Moriarty et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RB Davis United States	9	518	417	384	300	249	14	1.1k
G A Omura United States	11	409 0.8×	241 0.6×	108 0.3×	295 1.0×	206 0.8×	18	1.2k
Jieun Uhm Canada	16	338 0.7×	275 0.7×	182 0.5×	360 1.2×	145 0.6×	57	876
C.F. LeMaistre United States	15	451 0.9×	122 0.3×	176 0.5×	367 1.2×	91 0.4×	27	829
Anastasios Raptis United States	15	465 0.9×	93 0.2×	280 0.7×	352 1.2×	185 0.7×	50	994
Anna Mestice Italy	17	554 1.1×	60 0.1×	227 0.6×	143 0.5×	275 1.1×	39	870
Leonard M. Klein United States	14	205 0.4×	134 0.3×	234 0.6×	432 1.4×	220 0.9×	49	834
Burton J. Lee United States	15	220 0.4×	237 0.6×	191 0.5×	436 1.5×	166 0.7×	19	952
D E Bergsagel Canada	11	487 0.9×	122 0.3×	150 0.4×	299 1.0×	285 1.1×	17	832
Jorge A. Spinolo United States	11	379 0.7×	70 0.2×	90 0.2×	436 1.5×	150 0.6×	18	794
J. L. Harousseau France	14	436 0.8×	50 0.1×	163 0.4×	293 1.0×	199 0.8×	35	812

Countries citing papers authored by RB Davis

Since Specialization

Citations

This map shows the geographic impact of RB Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RB Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RB Davis more than expected).

Fields of papers citing papers by RB Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RB Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RB Davis. The network helps show where RB Davis may publish in the future.

Co-authorship network of co-authors of RB Davis

This figure shows the co-authorship network connecting the top 25 collaborators of RB Davis. A scholar is included among the top collaborators of RB Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RB Davis. RB Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Sennino, Barbara, RB Davis, James G. Christensen, et al.. (2006). 78 POSTER Combined anti-VEGFR and anti-PDGFR actions of sunitinib on blood vessels in preclinical tumor models. European Journal of Cancer Supplements. 4(12). 27–28. 14 indexed citations

2.

Alexander, E, Thomas M. Moriarty, RB Davis, et al.. (1995). Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases. JNCI Journal of the National Cancer Institute. 87(1). 34–40. 447 indexed citations breakdown →

3.

Ball, ED, RB Davis, JD Griffin, et al.. (1991). Prognostic value of lymphocyte surface markers in acute myeloid leukemia [see comments]. Blood. 77(10). 2242–2250.

4.

Ball, ED, RB Davis, JD Griffin, et al.. (1991). Prognostic value of lymphocyte surface markers in acute myeloid leukemia [see comments]. Blood. 77(10). 2242–2250. 119 indexed citations

5.

Davis, RB, R B Weiss, Stephen Caplan, et al.. (1991). A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood. 78(10). 2520–2526. 6 indexed citations

6.

Davis, RB, R B Weiss, Stephen Caplan, et al.. (1991). A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood. 78(10). 2520–2526. 124 indexed citations

7.

Davey, Frederick R., RB Davis, Douglas A. Nelson, et al.. (1989). Morphologic and cytochemical characteristics of acute promyelocytic leukemia. American Journal of Hematology. 30(4). 221–227. 39 indexed citations

8.

Capizzi, Robert L., RB Davis, Bayard L. Powell, et al.. (1988). Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study.. Journal of Clinical Oncology. 6(3). 499–508. 61 indexed citations

9.

Schulman, Philip, et al.. (1987). Phase II study of continuous-infusion diaziquone in relapsed/refractory acute nonlymphocytic leukemia.. PubMed. 71(7-8). 755–7. 9 indexed citations

10.

Preisler, Harvey D., RB Davis, Jeffrey J. Kirshner, et al.. (1987). Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.. Blood. 69(5). 1441–9. 225 indexed citations

11.

R., K., Janet Cuttner, J F Holland, et al.. (1987). Therapeutic Strategies in Acute Myelocytic Leukemia: A Status Report of the Experience of CALGB. Hämatologie und Bluttransfusion. 30. 31–34. 1 indexed citations

12.

Schiffer, CA, et al.. (1987). Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study.. PubMed. 71(9). 879–80. 4 indexed citations

13.

Schulman, Philip, et al.. (1984). Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.. PubMed. 68(10). 1305–6. 6 indexed citations

14.

Jm, Ward, et al.. (1976). Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.. PubMed. 60(11). 1675–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact